Jonathan L. Isaacsohn

Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)

Harold Bays, Christie M. Ballantyne, John J.P. Kastelein et al. · The American Journal of Cardiology · 2011 · 345 citations

Metabolic Syndrome, Lipid Disorder, Cardiovascular Disease +7

Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease

Samuel R. Money, J. Alan Herd, Jonathan L. Isaacsohn et al. · Journal of Vascular Surgery · 1998 · 336 citations

Kinesiology, Intermittent Claudication, Cardiovascular Disease +3

Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)

Christie M. Ballantyne, Harold Bays, John J.P. Kastelein et al. · The American Journal of Cardiology · 2012 · 331 citations

Metabolic Syndrome, Lipid Disorder, Cardiovascular Disease +8

Efficacy and Safety of Lovastatin in Adolescent Males With Heterozygous Familial Hypercholesterolemia

Evan A. Stein, D. Roger Illingworth, Peter O. Kwiterovich et al. · JAMA · 1999 · 273 citations

A study of twins and stroke.

Lawrence Brass, Jonathan L. Isaacsohn, Kathleen R. Merikangas et al. · Stroke · 1992 · 255 citations